ZA957795B - [1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use - Google Patents

[1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use

Info

Publication number
ZA957795B
ZA957795B ZA957795A ZA957795A ZA957795B ZA 957795 B ZA957795 B ZA 957795B ZA 957795 A ZA957795 A ZA 957795A ZA 957795 A ZA957795 A ZA 957795A ZA 957795 B ZA957795 B ZA 957795B
Authority
ZA
South Africa
Prior art keywords
pct
triazolo
date mar
substituted
pox
Prior art date
Application number
ZA957795A
Other languages
English (en)
Inventor
Flemming Elmelund Nielsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA957795B publication Critical patent/ZA957795B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA957795A 1994-09-16 1995-09-15 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use ZA957795B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK106594 1994-09-16

Publications (1)

Publication Number Publication Date
ZA957795B true ZA957795B (en) 1996-05-14

Family

ID=8100599

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957795A ZA957795B (en) 1994-09-16 1995-09-15 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use

Country Status (23)

Country Link
US (1) US6001832A (zh)
EP (1) EP0783504B1 (zh)
JP (1) JPH10505601A (zh)
CN (1) CN1083842C (zh)
AT (1) ATE190616T1 (zh)
AU (1) AU706737B2 (zh)
CA (1) CA2200055A1 (zh)
CZ (1) CZ285248B6 (zh)
DE (1) DE69515680T2 (zh)
DK (1) DK0783504T3 (zh)
ES (1) ES2146769T3 (zh)
FI (1) FI971075A (zh)
GR (1) GR3033642T3 (zh)
HU (1) HUT76810A (zh)
IL (1) IL115300A (zh)
NO (1) NO308796B1 (zh)
NZ (1) NZ292107A (zh)
PL (1) PL319176A1 (zh)
PT (1) PT783504E (zh)
RU (1) RU2149162C1 (zh)
SK (1) SK282635B6 (zh)
WO (1) WO1996008492A1 (zh)
ZA (1) ZA957795B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024434A1 (en) 1997-11-11 1999-05-20 Ono Pharmaceutical Co., Ltd. Fused pyrazine compounds
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
AU2010219598A1 (en) 2009-03-05 2011-09-22 Astellas Pharma Inc. Quinoxaline compounds
CA2810659A1 (en) 2010-09-07 2012-03-15 Astellas Pharma Inc. Quinoxaline compound
BR112013005855A2 (pt) * 2010-09-16 2016-05-17 Hutchison Medipharma Ltd heteroarilas fundidas e seus usos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
AU3767793A (en) * 1992-04-03 1993-11-08 Yamanouchi Pharmaceutical Co., Ltd. Fused quinoxalinone derivative and pharmaceutical composition containing the same
DK31093D0 (zh) * 1993-03-19 1993-03-19 Novo Nordisk As
WO1994026746A1 (en) * 1993-05-06 1994-11-24 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE

Also Published As

Publication number Publication date
JPH10505601A (ja) 1998-06-02
ATE190616T1 (de) 2000-04-15
WO1996008492A1 (en) 1996-03-21
SK33597A3 (en) 1998-02-04
RU2149162C1 (ru) 2000-05-20
CZ285248B6 (cs) 1999-06-16
IL115300A (en) 2001-06-14
FI971075A (fi) 1997-05-13
EP0783504B1 (en) 2000-03-15
CN1083842C (zh) 2002-05-01
NO971186L (no) 1997-05-15
DE69515680D1 (de) 2000-04-20
PT783504E (pt) 2000-08-31
AU3380795A (en) 1996-03-29
DE69515680T2 (de) 2000-10-19
DK0783504T3 (da) 2000-08-14
US6001832A (en) 1999-12-14
AU706737B2 (en) 1999-06-24
CZ75497A3 (en) 1997-08-13
CN1193974A (zh) 1998-09-23
NO971186D0 (no) 1997-03-14
IL115300A0 (en) 1995-12-31
EP0783504A1 (en) 1997-07-16
GR3033642T3 (en) 2000-10-31
NO308796B1 (no) 2000-10-30
HUT76810A (en) 1997-11-28
PL319176A1 (en) 1997-08-04
FI971075A0 (fi) 1997-03-14
NZ292107A (en) 1999-02-25
ES2146769T3 (es) 2000-08-16
SK282635B6 (sk) 2002-10-08
CA2200055A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
ATE192151T1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE3671370D1 (de) Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel.
ES2010071A6 (es) Procedimiento para preparar derivados de isoquinolina.
PL322134A1 (en) Trisubstituted phenyl derivatives
ATE218860T1 (de) Verwendung von 3,4-diphenylchromanen zur herstellung eines arzneimittels zur behandlung bzw. vorbeugung des prostatakarzinoms
GR3033642T3 (en) [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
TW254945B (zh)
AU3160995A (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
GR3034226T3 (en) 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
MY122667A (en) Benzofuran derivatives
GB9513750D0 (en) Use of allylamines
NO971187D0 (no) £1,2,4|triazolo£4,3-a|kinoksalinonderivater, deres fremstilling og anvendelse
ES8705405A1 (es) Procedimiento de preparar nuevos derivados morfolinicos
PL311296A1 (en) Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents
IL149308A0 (en) Use of 1-aminoindan derivatives for treatment of manic disorders
AR010978A1 (es) Procedimiento para inhibir tumores de colon